Paul Bisaro - 04 Jun 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Director
Issuer ticker: MYGN
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jun 2026, 16:24:55 UTC
Prior SEC filing: 04 Jun 2026
Next SEC filing: 17 Jul 2026
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Paul Bisaro

Key filing fact

Paul Bisaro filed Form 4 for MYRIAD GENETICS INC (MYGN) on 05 Jun 2026.

Key facts

This page summarizes Paul Bisaro's Form 4 filing for MYRIAD GENETICS INC (MYGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 16:24.

Change

Previous filing in this sequence was filed on 04 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001237253 Primary reporting owner

Bisaro Paul

Relationship: Director
Address: 322 NORTH 2200 WEST, SALT LAKE CITY
Signature: By: Justin Hunter For: Paul Bisaro
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Award

Transaction value
Shares: +59,701
Change %: +61%
Price: $0.000000^*
Shares after: 157,142
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.